Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

West Pharmaceutical Services (NY: WST )

374.07 -11.66 (-3.02%)
Streaming Delayed Price Updated: 12:38 PM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 334,685
Open 384.48
Bid (Size) 373.26 (4)
Ask (Size) 374.55 (4)
Prev. Close 385.73
Today's Range 364.89 - 390.33
52wk Range 310.42 - 415.73
Shares Outstanding 73,500,000
Dividend Yield 0.20%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
WST Stock Earnings: West Pharmaceutical Servs Beats EPS, Beats Revenue for Q1 2024
WST stock results show that West Pharmaceutical Servs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Why the dividend investor may take a look at NYSE:WST.
Via Chartmill

Performance

YTD
+7.28%
+7.28%
1 Month
-3.69%
-3.69%
3 Month
+7.27%
+7.27%
6 Month
+4.49%
+4.49%
1 Year
+4.78%
+4.78%

More News

Read More
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
Via Benzinga
Exploring NYSE:WST's dividend characteristics.
Via Chartmill
3 Pharma Stocks to Sell in March Before They Crash & Burn
Via InvestorPlace
Analyzing NYSE:WST's Dividend Potential.
Via Chartmill
S&P Reclaims 5,000 As Disappointing Retail Sales Put Fed Cuts Back On Track, Small Caps Shine: What's Driving Markets Thursday?
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
West Pharmaceutical's 2024 Outlook Cautious, Analysts Remain Optimistic
Via Benzinga
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
Via Benzinga
West Pharmaceutical Sets 2024 EPS Guidance at $7.50-$7.75
Via Talk Markets
Earnings Scheduled For February 15, 2024
Via Benzinga
Why WEST PHARMACEUTICAL SERVICES (NYSE:WST) qualifies as a quality stock.
Via Chartmill
Keybanc Maintains Overweight Rating for West Pharmaceutical Servs: Here's What You Need To Know
Via Benzinga
TransDigm, West Pharmaceutical, Thermo Fisher Scientific And A Tech Company On CNBC's 'Final Trades'
Via Benzinga
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 10 Years
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $20,000 Today
Via Benzinga
West Pharmaceutical Services Bullish Daily Cycle
Via Talk Markets
Here's How Much $100 Invested In West Pharmaceutical Servs 15 Years Ago Would Be Worth Today
Via Benzinga
How Is The Market Feeling About West Pharmaceutical Servs?
Via Benzinga
How Is The Market Feeling About West Pharmaceutical Servs?
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,300 Today
Via Benzinga
Here's How Much $1000 Invested In West Pharmaceutical Servs 5 Years Ago Would Be Worth Today
Via Benzinga
Blue-Chip Bargains: Top 3 Oversold Aristocrats for Value Investors
Via InvestorPlace
Looking Into West Pharmaceutical Servs's Recent Short Interest
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.